Figure 1
From: Disparities in medical recommendations from AI-based chatbots across different countries/regions
The research protocols. Based on public data, six endometrial cancer patient cases were examined as patient scenarios (1). Six patient cases were tested in Indonesia, Nigeria, Taiwan, and the United States using three AI-based chatbots (Bing, Bard, and ChatGPT-3.5) (2). Answers from each chatbot in the 4 locations were coded and randomized (3). A panel of ten gynecologic oncologists analysed and scored the responses from each chatbot (4). Data analysis and statistical computations were used to determine the importance and compare the results of each chatbot's responses in different places (5). Use diagrams and tables to present study findings and conclusions (6).
